Pricing Log in Create free account

LENSAR, Inc. (LNSR) vs Lucid Diagnostics Inc. (LUCD)

LENSAR, Inc. and Lucid Diagnostics Inc. are both Medical Devices companies. Lucid Diagnostics Inc. is the larger, with a market value of $105.7M against $74.1M — 1.4× the size. Lucid Diagnostics Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 2.0×. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against 3.26%. LENSAR, Inc. has the higher net margin (57.6% vs −1,193.9%) and the higher return on invested capital (−379.0% vs −3,096.5%). Across the 17 metrics below, LENSAR, Inc. leads on 13 and Lucid Diagnostics Inc. on 4.

Valuation

Metric LNSR LUCD Medical Devices median
P/E 2.04 n/m 23.22
P/S 1.18 16.14 2.34
P/B 4.79 8.04 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 1.06 14.32 2.24
Earnings yield 49.05% (97.92%) (10.09%)
Free cash flow yield (10.38%) (53.68%) (8.47%)

Profitability

Metric LNSR LUCD Medical Devices median
Gross margin 48.34% (21.69%) 56.01%
Operating margin (13.48%) (930.84%) (15.03%)
Net margin 57.57% (1,193.87%) (20.40%)
Free cash flow margin (12.29%) (866.56%) (7.24%)
Return on equity (851.75%) 364.89% (15.32%)
Return on assets 49.58% (167.51%) (19.72%)
Return on invested capital (379.01%) (3,096.53%) (10.33%)

Growth

Metric LNSR LUCD Medical Devices median
Revenue growth (TTM) 3.26% 24.89% 8.80%
EPS growth (last fiscal year) (5.13%) 34.29% 29.03%
Revenue growth, 5-year CAGR 17.24% — 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNSR LUCD Medical Devices median
Debt to equity 0.00 2.15 0.07
Current ratio 2.39 1.33 2.50
Net debt to EBITDA 0.89 0.22 0.49

Dividend

Metric LNSR LUCD Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric LNSR LUCD Medical Devices median
Market cap 74.09m 105.71m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack